BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35007959)

  • 41. Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples.
    Migueres M; Mansuy JM; Vasseur S; Claverie N; Lougarre C; Soulier F; Trémeaux P; Izopet J
    Microbiol Spectr; 2022 Dec; 10(6):e0252122. PubMed ID: 36318040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of next generation diagnostic systems (NGDS) for the detection of SARS-CoV-2.
    Sanchez AO; Ochoa AR; Hall SL; Voelker CR; Mahoney RE; McDaniel JS; Blackburn A; Asin SN; Yuan TT
    J Clin Lab Anal; 2022 Apr; 36(4):e24285. PubMed ID: 35174538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Evaluation of AccuPower COVID-19 Multiplex Real-Time RT-PCR Kit and AccuPower SARS-CoV-2 Multiplex Real-Time RT-PCR Kit for SARS-CoV-2 Detection in Sputum, NPS/OPS, Saliva and Pooled Samples.
    Suh IB; Lim J; Kim HS; Rhim G; Kim H; Kim H; Lee SM; Park HS; Song HJ; Hong M; Shin GS; Kim MJ
    PLoS One; 2022; 17(2):e0263341. PubMed ID: 35143538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR.
    Tsujimoto Y; Terada J; Kimura M; Moriya A; Motohashi A; Izumi S; Kawajiri K; Hakkaku K; Morishita M; Saito S; Takumida H; Watanabe H; Tsukada A; Morita C; Yamaguchi Y; Katsuno T; Kusaba Y; Sakamoto K; Hashimoto M; Suzuki M; Takasaki J; Hojo M; Miyoshi-Akiyama T; Sugiyama H
    Infect Dis (Lond); 2021 Aug; 53(8):581-589. PubMed ID: 33760699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test.
    Hofman P; Allegra M; Salah M; Benzaquen J; Tanga V; Bordone O; Fayada J; Long-Mira E; Lassalle S; Lanteri E; Lespinet-Fabre V; Brest P; Mograbi B; Maniel C; Boutros J; Leroy S; Heeke S; Hofman V; Marquette CH; Ilié M
    Microbiol Spectr; 2021 Dec; 9(3):e0099621. PubMed ID: 34756076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salivary SARS-CoV-2 RNA for diagnosis of COVID-19 patients: a systematic revisew and meta-analysis of diagnostic accuracy.
    Caixeta DC; Paranhos LR; Blumenberg C; Garcia-Júnior MA; Guevara-Vega M; Taveira EB; Nunes MAC; Cunha TM; Jardim ACG; Flores-Mir C; Sabino-Silva R
    Jpn Dent Sci Rev; 2023 Jun; 59():219-38. PubMed ID: 37360001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2.
    Carrouel F; Valette M; Perrier H; Bouscambert-Duchamp M; Dussart C; Tramini P; Bourgeois D
    Viruses; 2021 May; 13(5):. PubMed ID: 34066046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparing SARS-CoV-2 Testing in Anterior Nasal Vestibular Swabs vs. Oropharyngeal Swabs.
    Li M; Wei R; Yang Y; He T; Shen Y; Qi T; Han T; Song Z; Zhu Z; Ma X; Lin Y; Yuan Y; Zhao K; Lu H; Zhou X
    Front Cell Infect Microbiol; 2021; 11():653794. PubMed ID: 34307187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients.
    Procop GW; Shrestha NK; Vogel S; Van Sickle K; Harrington S; Rhoads DD; Rubin BP; Terpeluk P
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32883744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings?
    Masse S; Bonnet C; Vilcu AM; Benamar H; Swital M; van der Werf S; Carrat F; Hanslik T; Blanchon T; Falchi A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33926069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
    Chen JH; Yip CC; Poon RW; Chan KH; Cheng VC; Hung IF; Chan JF; Yuen KY; To KK
    Emerg Microbes Infect; 2020 Dec; 9(1):1356-1359. PubMed ID: 32459137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a novel anterior nasal swab for the detection of SARS-CoV-2.
    Crowe A; Lorenzo YP; Jardine D; Visvanathan K
    J Virol Methods; 2023 Jun; 316():114713. PubMed ID: 36934898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.
    Liu M; Li Q; Zhou J; Ai W; Zheng X; Zeng J; Liu Y; Xiang X; Guo R; Li X; Wu X; Xu H; Jiang L; Zhang H; Chen J; Tian L; Luo J; Luo C
    J Virol Methods; 2020 Dec; 286():113974. PubMed ID: 32949663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study.
    Altawalah H; AlHuraish F; Alkandari WA; Ezzikouri S
    J Clin Virol; 2020 Nov; 132():104652. PubMed ID: 33053493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients.
    Landry ML; Criscuolo J; Peaper DR
    J Clin Virol; 2020 Sep; 130():104567. PubMed ID: 32750665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined oropharyngeal/nasal swab is equivalent to nasopharyngeal sampling for SARS-CoV-2 diagnostic PCR.
    Desmet T; Paepe P; Boelens J; Coorevits L; Padalko E; Vandendriessche S; Leroux-Roels I; Aerssens A; Callens S; Braeckel EV; Malfait T; Vermassen F; Verhasselt B
    BMC Microbiol; 2021 Jan; 21(1):31. PubMed ID: 33482729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 on Self-Collected Saliva or Anterior Nasal Specimens Compared With Healthcare Personnel-Collected Nasopharyngeal Specimens.
    Marx GE; Biggerstaff BJ; Nawrocki CC; Totten SE; Travanty EA; Burakoff AW; Scott T; De Hey JC; Carlson JJ; Wendel KA; Harcourt JL; Tamin A; Thomas JD; Rowan SE; ;
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S65-S73. PubMed ID: 33912930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant.
    Bordi L; Sberna G; Lalle E; Fabeni L; Mazzotta V; Lanini S; Corpolongo A; Garbuglia AR; Nicastri E; Girardi E; Vaia F; Antinori A; Maggi F
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of sample pooling for SARS-CoV-2 RNA detection in nasopharyngeal swabs and salivas on the Roche Cobas 6800.
    McMillen T; Jani K; Babady NE
    J Clin Virol; 2021 May; 138():104790. PubMed ID: 33770658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.